A pilot feasibility study to evaluate the efficacy of lapatinib in eliminating HER2-positive tumor cells circulating in peripheral blood of women with metastatic breast cancer.
Sofia Agelaki
No relevant relationships to disclose
Antonia Kalykaki
No relevant relationships to disclose
Haris Markomanolaki
No relevant relationships to disclose
Galatea Kallergi
No relevant relationships to disclose
Kostas Kalbakis
No relevant relationships to disclose
Dimitrios Mavroudis
No relevant relationships to disclose
Vassilis Georgoulias
Consultant or Advisory Role - GlaxoSmithKline
Honoraria - GlaxoSmithKline
Research Funding - GlaxoSmithKline